PROPANC BIOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $306.8K | $10.8M | $132 |
| FY2012 | $584.2K | $46.3K | $179 |
| FY2013 | $794.2K | $1.7K | $0 |
| FY2014 | $1.5M | $113.7K | $87.8K |
| FY2015 | $3.7M | $627.1K | — |
| FY2016 | $2.9M | $379.1K | — |
| FY2017 | $5.5M | $95.1K | — |
| FY2018 | $6.8M | $71.4K | — |
| FY2019 | $4.4M | $101.7K | — |
| FY2020 | $3.7M | $98.5K | $67.0K |
| FY2021 | $3.1M | $13.1K | $2.3K |
| FY2022 | $3.1M | $81.7K | $4.1K |
| FY2023 | $3.2M | $60.3K | — |
| FY2024 | $3.9M | $72.4K | — |
| FY2025 | $5.7M | $19.6M | — |